These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7499858)

  • 1. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase.
    Mĕlková Z; Esteban M
    J Immunol; 1995 Dec; 155(12):5711-8. PubMed ID: 7499858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites.
    Karupiah G; Harris N
    J Exp Med; 1995 Jun; 181(6):2171-9. PubMed ID: 7539042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes.
    Drillien R; Spehner D; Bohbot A; Hanau D
    Virology; 2000 Mar; 268(2):471-81. PubMed ID: 10704355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus.
    Lee SB; Esteban M
    Virology; 1993 Apr; 193(2):1037-41. PubMed ID: 8096351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line.
    Mĕlková Z; Esteban M
    Virology; 1994 Feb; 198(2):731-5. PubMed ID: 8291253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors.
    De Silva FS; Moss B
    Virol J; 2005 Mar; 2():23. PubMed ID: 15784143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
    Ramsey-Ewing A; Moss B
    Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation.
    Granja AG; Sabina P; Salas ML; Fresno M; Revilla Y
    J Virol; 2006 Nov; 80(21):10487-96. PubMed ID: 17041221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
    Yu JS; Tsai HC; Wu CC; Weng LP; Li HP; Chung PJ; Chang YS
    Oncogene; 2002 Nov; 21(52):8047-61. PubMed ID: 12439755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A(2) receptor-mediated PKA activation.
    Leão-Ferreira LR; Paes-De-Carvalho R; De Mello FG; Moussatché N
    Arch Virol; 2002 Jul; 147(7):1407-23. PubMed ID: 12111415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
    Esteban M; Patiño C
    J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antiviral effect of nitric oxide: inhibition of reovirus replication.
    Pertile TL; Karaca K; Sharma JM; Walser MM
    Avian Dis; 1996; 40(2):342-8. PubMed ID: 8790884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin differentially inhibits picornavirus, herpesvirus and poxvirus replication in a human carcinoma cell line.
    Nørskov-Lauritsen N; Ebbesen P
    In Vivo; 1993; 7(6A):481-5. PubMed ID: 7514894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.
    Rolph MS; Cowden WB; Medveczky CJ; Ramshaw IA
    J Virol; 1996 Nov; 70(11):7678-85. PubMed ID: 8892888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of polyadenylated nontranslated small RNA sequences (POLADS) during superinfection correlates with the inhibition of viral and cellular protein synthesis.
    Bablanian R; Scribani S; Esteban M
    Cell Mol Biol Res; 1993; 39(3):243-55. PubMed ID: 7507390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
    Rolph MS; Ramshaw IA; Rockett KA; Ruby J; Cowden WB
    Virology; 1996 Mar; 217(2):470-7. PubMed ID: 8610438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.